Emerging Markets Regulatory Tracker: Brazil, China (Vol. 4 No. 26)
This article was originally published in PharmAsia News
Executive Summary
Brazil has expedited the process to import high-risk medical devices, while China FDA looks to target the Internet on illegal drug sales.